Scott T. Moe

519 total citations
20 papers, 415 citations indexed

About

Scott T. Moe is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Scott T. Moe has authored 20 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Scott T. Moe's work include Neuroscience and Neuropharmacology Research (5 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Ion channel regulation and function (4 papers). Scott T. Moe is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Ion channel regulation and function (4 papers). Scott T. Moe collaborates with scholars based in United States and South Africa. Scott T. Moe's co-authors include Philip S. Portoghese, A.E. Takemori, K Raynor, Terry Reisine, Hyesik Kong, Graeme I. Bell, Kazuki Yasuda, Alan R. Jacobson, John P. Long and Joseph G. Cannon and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Scott T. Moe

20 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott T. Moe United States 11 271 248 61 52 33 20 415
Po‐wai Yuen United States 7 322 1.2× 198 0.8× 89 1.5× 42 0.8× 13 0.4× 7 563
Venkatesalu Bakthavachalam United States 14 307 1.1× 260 1.0× 93 1.5× 21 0.4× 10 0.3× 23 420
John R. Boot United Kingdom 13 214 0.8× 127 0.5× 99 1.6× 86 1.7× 11 0.3× 26 458
F. Ivy Carroll United States 8 217 0.8× 272 1.1× 69 1.1× 40 0.8× 12 0.4× 9 406
Leticia Toledo‐Sherman United States 14 273 1.0× 96 0.4× 32 0.5× 32 0.6× 9 0.3× 21 416
Toshiharu Nagatsu Japan 7 101 0.4× 174 0.7× 58 1.0× 156 3.0× 20 0.6× 7 330
Jon K. Reel United States 11 242 0.9× 212 0.9× 75 1.2× 15 0.3× 14 0.4× 14 393
Shigeto Kitamura Japan 11 171 0.6× 104 0.4× 95 1.6× 96 1.8× 14 0.4× 24 440
J Knoth United States 11 288 1.1× 171 0.7× 18 0.3× 28 0.5× 7 0.2× 13 515
Steven D. Heck United States 9 238 0.9× 125 0.5× 62 1.0× 10 0.2× 10 0.3× 10 405

Countries citing papers authored by Scott T. Moe

Since Specialization
Citations

This map shows the geographic impact of Scott T. Moe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott T. Moe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott T. Moe more than expected).

Fields of papers citing papers by Scott T. Moe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott T. Moe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott T. Moe. The network helps show where Scott T. Moe may publish in the future.

Co-authorship network of co-authors of Scott T. Moe

This figure shows the co-authorship network connecting the top 25 collaborators of Scott T. Moe. A scholar is included among the top collaborators of Scott T. Moe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott T. Moe. Scott T. Moe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smagghe, Benoit J., Mark G. Carter, Daniel M. Miller, et al.. (2025). Effective CAR T-cell targeting of an MUC1 cleavage product. Journal for ImmunoTherapy of Cancer. 13(5). e010577–e010577. 1 indexed citations
2.
Bamdad, Cynthia, et al.. (2020). Abstract P3-11-11: First-in-human CAR T for solid tumors targets the MUC1 transmembrane cleavage product. Cancer Research. 80(4_Supplement). P3–11. 2 indexed citations
3.
Bamdad, Cynthia, Andrew K. Stewart, Benoit J. Smagghe, et al.. (2019). First-in-human CAR T for solid tumors targets the MUC1 transmembrane cleavage product. Cytotherapy. 21(5). S9–S9. 2 indexed citations
4.
Thyagarajan, Baskaran, Joseph G. Potian, Kateřina Čapková, et al.. (2010). Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions. Neuropharmacology. 58(8). 1189–1198. 13 indexed citations
5.
Stowe, G. Neil, Peter Šilhár, Mark S. Hixon, et al.. (2010). Chirality Holds the Key for Potent Inhibition of the Botulinum Neurotoxin Serotype A Protease. Organic Letters. 12(4). 756–759. 22 indexed citations
6.
Moe, Scott T., et al.. (2009). Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs. Bioorganic & Medicinal Chemistry. 17(8). 3072–3079. 29 indexed citations
7.
Jacobson, Alan R., Scott T. Moe, Paul D. Allen, & James D. Fessenden. (2006). Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1. Molecular Pharmacology. 70(1). 259–266. 11 indexed citations
8.
Moe, Scott T., Eric G. DelMar, Bradford C. Van Wagenen, et al.. (2000). Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 10(21). 2411–2415. 10 indexed citations
9.
Mueller, Alan L., Linda D. Artman, Manuel F. Balandrin, et al.. (2000). NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience. Amino Acids. 19(1). 177–179. 3 indexed citations
10.
Mueller, Alan L., Linda D. Artman, Manuel F. Balandrin, et al.. (1999). NPS 1506, A Novel NMDA Receptor Antagonist and Neuroprotectant: Review of Preclinical and Clinical Studies. Annals of the New York Academy of Sciences. 890(1). 450–457. 22 indexed citations
11.
Moe, Scott T., Bradford C. Van Wagenen, Eric G. DelMar, et al.. (1999). Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 9(14). 1915–1920. 10 indexed citations
12.
Moe, Scott T., et al.. (1998). Design, Synthesis, and Biological Evaluation of Spider Toxin (Argiotoxin-636) Analogs as NMDA Receptor Antagonists. Pharmaceutical Research. 15(1). 31–38. 14 indexed citations
13.
Moe, Scott T., et al.. (1998). Stereospecific Synthesis of Pseudocodeine:  [2,3]-Sigmatropic Rearrangement Using Selenium Intermediates. The Journal of Organic Chemistry. 63(5). 1704–1705. 12 indexed citations
14.
Moe, Scott T., et al.. (1998). Synthesis of 3,3-bis(3-fluorophenyl)-[2,3-3H2]-1-propanamine hydrochloride ([3H2]-NPS 846·HCl): a novel ligand for the NMDA receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 41(6). 535–543. 3 indexed citations
15.
Portoghese, Philip S., Rasheda Sultana, Scott T. Moe, & A.E. Takemori. (1994). Synthesis of naltrexone-derived .delta.-opioid antagonists. Role of conformation of the .delta. address moiety. Journal of Medicinal Chemistry. 37(5). 579–585. 34 indexed citations
16.
Portoghese, Philip S., Shigenori Ohkawa, Scott T. Moe, & A.E. Takemori. (1994). Synthesis and .delta.-Opioid Receptor Antagonist Activity of a Naltrindole Analog with a Regioisomeric Indole Moiety. Journal of Medicinal Chemistry. 37(12). 1886–1888. 5 indexed citations
17.
Portoghese, Philip S., Scott T. Moe, & A.E. Takemori. (1993). A selective .delta.1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for .delta.1 opioid receptor agonists and antagonists. Journal of Medicinal Chemistry. 36(17). 2572–2574. 57 indexed citations
18.
Cannon, Joseph G., et al.. (1993). Preparation and pharmacological evaluation of enantiomers of certain nonoxygenated aporphines: (+)- and (-)-aporphine and (+)- and (-)-10-methylaporphine. Journal of Medicinal Chemistry. 36(10). 1316–1318. 6 indexed citations
19.
Kong, Hyesik, K Raynor, Kazuki Yasuda, et al.. (1993). A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.. Journal of Biological Chemistry. 268(31). 23055–23058. 134 indexed citations
20.
Cannon, Joseph G., Scott T. Moe, & John P. Long. (1991). Enantiomers of 11‐hydroxy‐10‐methylaporphine having opposing pharmacological effects at 5‐HT1A receptors. Chirality. 3(1). 19–23. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Po‐wai Yuen Breakdown of academic impact, for papers by Venkatesalu Bakthavachalam Breakdown of academic impact, for papers by John R. Boot Breakdown of academic impact, for papers by F. Ivy Carroll Breakdown of academic impact, for papers by Leticia Toledo‐Sherman Breakdown of academic impact, for papers by Toshiharu Nagatsu Breakdown of academic impact, for papers by Jon K. Reel Breakdown of academic impact, for papers by Shigeto Kitamura Breakdown of academic impact, for papers by J Knoth Breakdown of academic impact, for papers by Steven D. Heck
Rankless by CCL
2026